Dr James M Ellison, MD | |
501 W 14th St, Swank Memory Care Center, Gateway Bldg, 5th Floor, Wilmington, DE 19801-1013 | |
(302) 320-2637 | |
(844) 634-0254 |
Full Name | Dr James M Ellison |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 46 Years |
Location | 501 W 14th St, Wilmington, Delaware |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144226630 | NPI | - | NPPES |
0164127 | Medicaid | MA |
Mailing Address | Practice Location Address |
---|---|
Dr James M Ellison, MD 501 W 14th St, Swank Memory Care Center, Gateway Bldg 5th Floor, Wilmington, DE 19801-1013 Ph: (302) 320-2637 | Dr James M Ellison, MD 501 W 14th St, Swank Memory Care Center, Gateway Bldg, 5th Floor, Wilmington, DE 19801-1013 Ph: (302) 320-2637 |
News Archive
Fully vaccinating children reduces the risk of hospitalization associated with influenza by 54%, according to a study by researchers at the University of Michigan, the Clalit Research Institute, and Ben-Gurion University in Israel.
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
In the battle against cancer, which kills nearly 8 million people worldwide each year, doctors have in their arsenal many powerful weapons, including various forms of chemotherapy and radiation. What they lack, however, is good reconnaissance — a reliable way to obtain real-time data about how well a particular therapy is working for any given patient.
The study, "Influence of early day care exposure on total IgE levels through age 3 years" can be found in the Articles in Press section of the JACI Web site, http://www.jacionline.org. The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).
Addex Pharmaceuticals has announced that it has completed the first part of a two-part Phase I clinical trial to evaluate the newly developed modified release formulation of ADX48621. ADX48621 is scheduled to start a Phase IIa proof of concept study for the treatment of levodopa associated dyskinesia in Parkinson's disease during the first half of 2009.
› Verified 9 days ago
Dr. Ranganathan Ram, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 410 Foulk Rd Ste 106, Wilmington, DE 19803 Phone: 302-762-2285 Fax: 302-762-2286 | |
Navjot Hanspal, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-2511 Fax: 302-633-5582 | |
Dr. Catherine F. Bodak-gyovai, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-651-5967 | |
Dr. Subani Maheshwari, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 W 14th Street, 1st Floor, Suite 1e40, Wilmington, DE 19801 Phone: 302-320-2100 Fax: 302-320-2121 | |
Dr. Dyanne Simpson, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 W 10th Street, Wilmington, DE 19801 Phone: 302-230-9154 Fax: 302-691-1100 | |
Dr. Troy L. Thompson Ii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 W 10th Street, Wilmington, DE 19801 Phone: 302-230-9192 Fax: 302-691-1100 | |
Carol Tavani, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 West 14th Street, 3rd Floor, Wilmington, DE 19801 Phone: 302-428-2100 Fax: 302-428-2121 |